606 related articles for article (PubMed ID: 11955017)
1. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils.
Cardoso I; Goldsbury CS; Müller SA; Olivieri V; Wirtz S; Damas AM; Aebi U; Saraiva MJ
J Mol Biol; 2002 Apr; 317(5):683-95. PubMed ID: 11955017
[TBL] [Abstract][Full Text] [Related]
2. Transthyretin forms amyloid fibrils at physiological pH with ultrasonication.
Misumi Y; Ueda M; Fujimori H; Shinriki S; Meng W; Kim J; Saito S; Obayashi K; Uchino M; Ando Y
Amyloid; 2008 Dec; 15(4):234-9. PubMed ID: 19065294
[TBL] [Abstract][Full Text] [Related]
3. Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrils.
Redondo C; Damas AM; Olofsson A; Lundgren E; Saraiva MJ
J Mol Biol; 2000 Dec; 304(3):461-70. PubMed ID: 11090287
[TBL] [Abstract][Full Text] [Related]
4. Chemical dissection and reassembly of amyloid fibrils formed by a peptide fragment of transthyretin.
MacPhee CE; Dobson CM
J Mol Biol; 2000 Apr; 297(5):1203-15. PubMed ID: 10764584
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrils.
Castro-Rodrigues AF; Gales L; Saraiva MJ; Damas AM
Acta Crystallogr D Biol Crystallogr; 2011 Dec; 67(Pt 12):1035-44. PubMed ID: 22120741
[TBL] [Abstract][Full Text] [Related]
6. The protofilament substructure of amyloid fibrils.
Serpell LC; Sunde M; Benson MD; Tennent GA; Pepys MB; Fraser PE
J Mol Biol; 2000 Jul; 300(5):1033-9. PubMed ID: 10903851
[TBL] [Abstract][Full Text] [Related]
7. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
Bergström J; Gustavsson A; Hellman U; Sletten K; Murphy CL; Weiss DT; Solomon A; Olofsson BO; Westermark P
J Pathol; 2005 Jun; 206(2):224-32. PubMed ID: 15810051
[TBL] [Abstract][Full Text] [Related]
8. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization.
Hurshman AR; White JT; Powers ET; Kelly JW
Biochemistry; 2004 Jun; 43(23):7365-81. PubMed ID: 15182180
[TBL] [Abstract][Full Text] [Related]
9. Structure and assembly-disassembly properties of wild-type transthyretin amyloid protofibrils observed with atomic force microscopy.
Pires RH; Saraiva MJ; Damas AM; Kellermayer MS
J Mol Recognit; 2011; 24(3):467-76. PubMed ID: 21504025
[TBL] [Abstract][Full Text] [Related]
10. Multiple assembly pathways underlie amyloid-beta fibril polymorphisms.
Goldsbury C; Frey P; Olivieri V; Aebi U; Müller SA
J Mol Biol; 2005 Sep; 352(2):282-98. PubMed ID: 16095615
[TBL] [Abstract][Full Text] [Related]
11. Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro.
Sousa MM; Fernandes R; Palha JA; Taboada A; Vieira P; Saraiva MJ
Am J Pathol; 2002 Nov; 161(5):1935-48. PubMed ID: 12414539
[TBL] [Abstract][Full Text] [Related]
12. Clusterin regulates transthyretin amyloidosis.
Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
[TBL] [Abstract][Full Text] [Related]
13. 4'-iodo-4'-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters.
Cardoso I; Merlini G; Saraiva MJ
FASEB J; 2003 May; 17(8):803-9. PubMed ID: 12724338
[TBL] [Abstract][Full Text] [Related]
14. Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy.
Misumi Y; Ando Y; Ueda M; Obayashi K; Jono H; Su Y; Yamashita T; Uchino M
J Pathol; 2009 Dec; 219(4):481-90. PubMed ID: 19790249
[TBL] [Abstract][Full Text] [Related]
15. The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions.
Lashuel HA; Wurth C; Woo L; Kelly JW
Biochemistry; 1999 Oct; 38(41):13560-73. PubMed ID: 10521263
[TBL] [Abstract][Full Text] [Related]
16. Transthyretin binding to A-Beta peptide--impact on A-Beta fibrillogenesis and toxicity.
Costa R; Gonçalves A; Saraiva MJ; Cardoso I
FEBS Lett; 2008 Mar; 582(6):936-42. PubMed ID: 18295603
[TBL] [Abstract][Full Text] [Related]
17. Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation.
Sato T; Ando Y; Susuki S; Mikami F; Ikemizu S; Nakamura M; Suhr O; Anraku M; Kai T; Suico MA; Shuto T; Mizuguchi M; Yamagata Y; Kai H
FEBS Lett; 2006 Jan; 580(2):491-6. PubMed ID: 16386248
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.
Lashuel HA; Lai Z; Kelly JW
Biochemistry; 1998 Dec; 37(51):17851-64. PubMed ID: 9922152
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
Green NS; Palaninathan SK; Sacchettini JC; Kelly JW
J Am Chem Soc; 2003 Nov; 125(44):13404-14. PubMed ID: 14583036
[TBL] [Abstract][Full Text] [Related]
20. Cys114-linked dimers of transthyretin are compatible with amyloid formation.
Karlsson A; Olofsson A; Eneqvist T; Sauer-Eriksson AE
Biochemistry; 2005 Oct; 44(39):13063-70. PubMed ID: 16185074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
